Cargando…

Multiple drugs: QTc prolongation leading to torsades-de-pointes and off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791948/ http://dx.doi.org/10.1007/s40278-021-89079-8

Ejemplares similares

Multiple drugs: QTc prolongation and torsades de pointes: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Multiple drugs: Off label use and QTc prolongation: case report
Publicado: (2021)

Multiple drugs: QTc prolongation and off-label use: case report
Publicado: (2021)

Torsade de Pointes and Persistent QTc Prolongation after Intravenous Amiodarone
por: Kotsia, Anna P., et al.
Publicado: (2012)

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020)

Multiple drugs: QTc prolongation, lack of efficacy and off-label use: 3 case reports
Publicado: (2021)

Multiple drugs: QTc interval prolongation following off-label use: 5 case reports
Publicado: (2022)

Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016)

Multiple drug interactions: QTc time prolongation following off-label use: 3 case reports
Publicado: (2022)

Hydroxychloroquine: Torsades de pointes following off label use: case report
Publicado: (2021)

Multiple drugs: QTc prolongation, hyperglycaemia, off label use and drug exposure during pregnancy: case report
Publicado: (2021)

Hydroxychloroquine: QTc prolongation following off-label-use: case report
Publicado: (2020)

Hydroxychloroquine: QTc-prolongation following an off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc prolongation following off-label use: case report
Publicado: (2020)

Chloroquine: QTc prolongation following off-label use: case report
Publicado: (2022)

Multiple drugs: Atrial fibrillation, Bradycardia, QTC interval prolongation and off label use: 2 case reports
Publicado: (2021)

Multiple drugs interaction: Reduction in drug level and QTc prolongation following off label use: 2 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsade-de-pointes following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsades-de-pointes following off label treatment: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsades de pointes following off-label use: case report
Publicado: (2021)

Correlation Between Donepezil and QTc Prolongation and Torsades de Pointes: A Very Rare Phenomenon
por: Malik, Bilal Haider, et al.
Publicado: (2019)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Hydroxychloroquine: Prolonged QTc interval following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation and off label use: 3 case reports.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation during off-label treatment: case report
Publicado: (2021)

Hydroxychloroquine: QTc interval prolonged following off label use: case report
Publicado: (2021)

Atazanavir/ritonavir: QTc prolongation following off-label treatment: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QTc during off label use: case report
Publicado: (2021)

Multiple drugs: Torsades de pointes and bradycardia: case report
Publicado: (2020)

Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives
por: Duan, Jialin, et al.
Publicado: (2018)

Hydroxychloroquine: Sinus bradycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Borderline prolongation of QTc interval during off-label treatment: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation following off-label use: 2 case reports
Publicado: (2021)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

Chloroquine: QTc interval prolongation leading to frequent extrasystoles and ventricular tachycardia following off label use: case report
Publicado: (2021)

Antivirals/fluoroquinolones: Prolongation of QTc interval following off-label use: 9 case reports
Publicado: (2021)

Chloroquine/erythromycin: QT interval prolongation and Torsade de Pointes: case report
Publicado: (2020)

Chloroquine/lopinavir/ritonavir/umifenovir: QTc interval prolongation, drug interaction and off-label use: 2 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Complete atrioventricular-block, torsades-de-pointes and QT-interval-prolongation following off label use: 2 case reports
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6rbq7j7pqes2jsaifgrhaaf436